Russian patient organizations ask Gilead to disclaim patents for Truvada
Call to action NewsOn 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...
Read more about Russian patient organizations ask Gilead to disclaim patents for Truvada
-
USA-Kenya Trade Agreement: No IP barriers to affordable medicines
Call to action News“Access to medicines is a fundamental element of the right to health” states our partner, the Kenya Legal and Ethical...
Read more about USA-Kenya Trade Agreement: No IP barriers to affordable medicines
-
CPTPP: Global civil society writes to Thai Prime Minister warning access to treatment is at risk
Call to action NewsCivil society groups and non-government organizations in Thailand have, since March 2020, been expressing their grave concerns over the adverse...
-
CSO Open Letter to Thailand’s Prime Minister
Call to action NewsCSO Open Letter to Thailand’s Prime Minister and the Chairperson of the Special Committee on the Study of the CPTPP’s...
Read more about CSO Open Letter to Thailand’s Prime Minister
-
Belarus: Civil society pushes for compulsory license as dolutegravir remains overpriced
Call to action NewsPositive Movement (PMPlus) in Belarus, one of our partner organizations, is an NGO representing people living with HIV, advocating for...
-
Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
Call to action News Press releaseThis week, civil society in Morocco has called for the urgent removal of unnecessary legal barriers, which are “tailor-made for...
Read more about Morocco: Parliament urged to ensure access to future COVID-19 treatment and vaccines
-
Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
Call to action NewsOur partner, Fundación GEP, has filed a patent opposition against Gilead’s patent application on remdesivir before the Argentinean Patent Office....
Read more about Argentina: Fundación GEP opposes Gilead’s patent application on remdesivir
-
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
Call to action NewsIn an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
-
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
-
Open letter: Prepare NOW for equitable access to COVID-19 treatments in Eastern Europe and Central Asia
Call to action NewsOrganizations working on health and rights in the Eastern Europe and Central Asia (EECA) region, have called on governments to...
